Tempest Therapeutics Inc. (NASDAQ: TPST)
$2.21
-0.0150 ( -0.68% ) 169.8K
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
Market Data
Open
$2.21
Previous close
$2.22
Volume
169.8K
Market cap
$48.99M
Day range
$2.20 - $2.26
52 week range
$0.17 - $9.77
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 56 | May 09, 2024 |
def | Proxies and info statements | 9 | Apr 23, 2024 |
ars | Annual reports | 1 | Apr 23, 2024 |
10-k | Annual reports | 78 | Mar 19, 2024 |
8-k | 8K-related | 13 | Mar 19, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 2 | Jan 05, 2024 |
4 | Insider transactions | 2 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
10-q | Quarterly Reports | 60 | Nov 08, 2023 |